Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 11/20 | 0.70 |
| ▸ | CTSK | P43235 | 9/20 | 0.70 |
| ▸ | CTSB | P07858 | 4/20 | 0.70 |
| ▸ | CTSL | P07711 | 3/20 | 0.70 |
| ▸ | AKT1 | P31749 | 1/20 | 0.60 |
| ▸ | ACE | P12821 | 1/20 | 0.60 |
| ▸ | PPARA | Q07869 | 2/20 | 0.58 |
| ▸ | REN | P00797 | 1/20 | 0.55 |
| ▸ | ATM | Q13315 | 1/20 | 0.55 |
| ▸ | PPARG | P37231 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4214524 | 1.00 | CTSS (0.70) | CTSSCTSKCTSBCTSLAKT1 | |
| SCHEMBL30279703 | 0.89 | CTSS (0.73) | CTSSCTSKCTSBCTSLAKT1 | |
| SCHEMBL6163314 | 0.89 | CTSS (0.73) | CTSSCTSKCTSBCTSLAKT1 | |
| SCHEMBL6163823 | 0.89 | CTSS (0.73) | CTSSCTSKCTSBCTSLAKT1 | |
| SCHEMBL6163323 | 0.89 | CTSS (0.73) | CTSSCTSKCTSBCTSLAKT1 | |
| SCHEMBL7269746 | 0.88 | CTSS (0.70) | CTSSCTSKCTSBCTSLAKT1 | |
| SCHEMBL7554167 | 0.87 | CTSS (0.67) | CTSSCTSKCTSBCTSLAKT1 | |
| SCHEMBL20669382 | 0.87 | CTSS (0.70) | CTSSCTSKCTSBCTSLAKT1 | |
| SCHEMBL8951298 | 0.86 | CTSS (0.73) | CTSSCTSKCTSBCTSLAKT1 | |
| SCHEMBL4216378 | 0.86 | CTSK (0.65) | CTSSCTSKCTSBCTSLAKT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090105091-A1 | Modified Amino Acids | TECHNISCHE UNIVERSITAT WIEN (AT) | 2009-04-23 | — | — | US | disclosed |
| EP-1989180-A1 | MODIFIED AMINO ACIDS | Technische Universität Wien (AT) | 2008-11-12 | — | — | EP | disclosed |
| WO-2007095980-A1 | MODIFIED AMINO ACIDS | TECHNISCHE UNIVERSITÄT WIEN (AT) | 2007-08-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090105091-A1 | Modified Amino Acids | SLC1A2, NR1H4, OXGR1 | CTSS 4519/4885CTSK 4083/4885CTSB 4458/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.